LT - Pharmaceutical formulations comprising salts of (5S,8S)-8-[{(1 R)-1-(3,5-Bis-trifluoromethyl)phenyl]- ethoxy}-methyl]-8-phenyl-1 ,7-diazaspiro[4.5]decan-2-one and their medical use
EN - Pharmaceutical formulations comprising salts of (5S,8S)-8-[{(1 R)-1-(3,5-Bis-trifluoromethyl)phenyl]- ethoxy}-methyl]-8-phenyl-1 ,7-diazaspiro[4.5]decan-2-one and their medical use
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 9/16 |
|
|
|
A61K 9/48 |
|
|
|
A61K 31/438 |
|
|
|
A61P 1/08 |
|
European patent
(11) |
Number of the document |
2004148 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
07774641.0 |
|
Date of filing the European patent application |
2007-04-04 |
(97) |
Date of publication of the European application |
2008-12-24 |
(45) |
Date of publication and mention of the grant of the patent |
2015-07-15
|
(46) |
Date of publication of the claims translation |
|
PCT application
(86) |
Number |
PCT/US2007/008345 |
|
Date |
2007-04-04 |
PCT application publication
(87) |
Number |
WO 2007/114921 |
|
Date |
2007-10-11 |
Priority applications
(30) |
Number |
Date |
Country code |
|
789514 P |
2006-04-05
|
US |
Inventors
(72) |
QIU, Zhihui, US
REYDERMAN, Larisa, US
|
Grantee
(73) |
OPKO Health, Inc.,
4400 Biscayne Blvd., Miami, FL 33137,
US
|
Title
(54) |
Pharmaceutical formulations comprising salts of (5S,8S)-8-[{(1 R)-1-(3,5-Bis-trifluoromethyl)phenyl]- ethoxy}-methyl]-8-phenyl-1 ,7-diazaspiro[4.5]decan-2-one and their medical use |
|
Pharmaceutical formulations comprising salts of (5S,8S)-8-[{(1 R)-1-(3,5-Bis-trifluoromethyl)phenyl]- ethoxy}-methyl]-8-phenyl-1 ,7-diazaspiro[4.5]decan-2-one and their medical use |